Verona Pharma plc (VRNA)

Verona Pharma Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year	2023	2022	2021	2020	2019
Net Income	-54.37	-68.7	-55.57	-65.15	-40.56
Depreciation & Amortization	0.68	0.64	0.63	0.62	0.51
Share-Based Compensation	19.01	14.12	25.43	22.18	3.12
Other Operating Activities	-15.54	-5.92	-3.74	-2.73	-5.94
Operating Cash Flow	-50.22	-59.86	-33.25	-45.08	-42.87
Capital Expenditures	0	-0.03	-0.01	-0.08	-0.05
Change in Investments	0	0	0	9.79	47.37
Investing Cash Flow	0	-0.03	-0.01	9.71	47.31
Share Issuance / Repurchase	58.86	151.17	0.73	200.2	0
Debt Issued / Paid	38.7	3.91	0	5	0
Other Financing Activities	-4.69	-14.26	-6.85	-12.86	-
Financing Cash Flow	92.87	140.82	-6.12	192.34	0
Exchange Rate Effect	1.3	-1.48	-0.22	0.58	0.74
Net Cash Flow	43.95	79.45	-39.61	157.56	5.19
Free Cash Flow	-50.22	-59.89	-33.27	-45.16	-42.92
Free Cash Flow Margin	-	-13076.64%	-83.17%	-	-
Free Cash Flow Per Share	-0.63	-0.91	-0.55	-1.05	-3.26

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).